Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Fluoroquinolone resistance in Streptococcus pneumoniae isolates in Germany from 2004-2005 to 2014-2015.

Schmitz J, van der Linden M, Al-Lahham A, Levina N, Pletz MW, Imöhl M.

Int J Med Microbiol. 2017 Jun;307(4-5):216-222. doi: 10.1016/j.ijmm.2017.04.003. Epub 2017 Apr 19.

PMID:
28506425
2.

Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece.

Syrogiannopoulos GA, Grivea IN, Al-Lahham A, Panagiotou M, Tsantouli AG, Michoula Ralf René Reinert AN, van der Linden M.

PLoS One. 2013 Aug 19;8(8):e71558. doi: 10.1371/journal.pone.0071558. eCollection 2013.

3.

Susceptibility to tuberculosis is associated with TLR1 polymorphisms resulting in a lack of TLR1 cell surface expression.

Uciechowski P, Imhoff H, Lange C, Meyer CG, Browne EN, Kirsten DK, Schröder AK, Schaaf B, Al-Lahham A, Reinert RR, Reiling N, Haase H, Hatzmann A, Fleischer D, Heussen N, Kleines M, Rink L.

J Leukoc Biol. 2011 Aug;90(2):377-88. doi: 10.1189/jlb.0409233. Epub 2011 Jun 3.

PMID:
21642391
4.

Superantigen genes are more important than the emm type for the invasiveness of group A Streptococcus infection.

Lintges M, van der Linden M, Hilgers RD, Arlt S, Al-Lahham A, Reinert RR, Plücken S, Rink L.

J Infect Dis. 2010 Jul 1;202(1):20-8. doi: 10.1086/653082.

PMID:
20497047
5.

Molecular characterization of pneumococcal isolates from pets and laboratory animals.

van der Linden M, Al-Lahham A, Nicklas W, Reinert RR.

PLoS One. 2009 Dec 14;4(12):e8286. doi: 10.1371/journal.pone.0008286.

6.

Mechanisms of macrolide resistance among Streptococcus pneumoniae isolates from Russia.

Reinert RR, Filimonova OY, Al-Lahham A, Grudinina SA, Ilina EN, Weigel LM, Sidorenko SV.

Antimicrob Agents Chemother. 2008 Jun;52(6):2260-2. doi: 10.1128/AAC.01270-07. Epub 2008 Mar 31.

7.

A new closed-tube multiplex real-time PCR to detect eleven superantigens of Streptococcus pyogenes identifies a strain without superantigen activity.

Lintges M, Arlt S, Uciechowski P, Plümäkers B, Reinert RR, Al-Lahham A, Lütticken R, Rink L.

Int J Med Microbiol. 2007 Oct;297(6):471-8. Epub 2007 May 3.

PMID:
17481952
8.

Molecular epidemiology of penicillin-non-susceptible Streptococcus pneumoniae isolates from children with invasive pneumococcal disease in Germany.

Reinert RR, van der Linden M, Seegmüller I, Al-Lahham A, Siedler A, Weissmann B, Toschke AM, von Kries R.

Clin Microbiol Infect. 2007 Apr;13(4):363-8.

9.

Time-kill kinetics of Streptococcus pneumoniae with reduced susceptibility to telithromycin.

Al-Lahham A, Reinert RR.

Chemotherapy. 2007;53(3):190-3. Epub 2007 Mar 7.

PMID:
17347565
10.

Clonal spread of mef-positive macrolide-resistant Streptococcus pneumoniae isolates causing invasive disease in adults in Germany.

van der Linden M, Al-Lahham A, Haupts S, Reinert RR.

Antimicrob Agents Chemother. 2007 May;51(5):1830-4. Epub 2007 Feb 26.

11.

Genetic diversity of pneumococcal surface protein A of Streptococcus pneumoniae meningitis in German children.

Heeg C, Franken C, van der Linden M, Al-Lahham A, Reinert RR.

Vaccine. 2007 Jan 22;25(6):1030-5. Epub 2006 Oct 2.

PMID:
17084949
12.

Telithromycin-nonsusceptible clinical isolates of Streptococcus pneumoniae from Europe.

Al-Lahham A, Appelbaum PC, van der Linden M, Reinert RR.

Antimicrob Agents Chemother. 2006 Nov;50(11):3897-900.

13.

Emergence of a unique multiply-antibiotic-resistant Streptococcus pneumoniae serotype 7B clone in Dhaka, Bangladesh.

Rahman M, Hossain S, Shoma S, Rashid H, Hel Baqui A, van der Linden M, Al-Lahham A, Reinert RR.

J Clin Microbiol. 2006 Dec;44(12):4625-7. Epub 2006 Sep 27. No abstract available.

14.
15.

Regional differences in the epidemiology of invasive pneumococcal disease in toddlers in Germany.

Siedler A, Reinert RR, Toschke M, Al-Lahham A, von Kries R; ESPED Clinic and Laboratory Study Group.

Pediatr Infect Dis J. 2005 Dec;24(12):1114-5.

PMID:
16371880
16.

Relationship between the original multiply resistant South African isolates of Streptococcus pneumoniae from 1977 to 1978 and contemporary international resistant clones.

Reinert RR, Jacobs MR, Appelbaum PC, Bajaksouzian S, Cordeiro S, van der Linden M, Al-Lahham A.

J Clin Microbiol. 2005 Dec;43(12):6035-41.

17.

Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001-2003.

Reinert RR, Haupts S, van der Linden M, Heeg C, Cil MY, Al-Lahham A, Fedson DS.

Clin Microbiol Infect. 2005 Dec;11(12):985-91.

18.

Activity of the new quinolones WCK 771, WCK 1152 and WCK 1153 against clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes.

Al-Lahham A, De Souza NJ, Patel M, René Reinert R.

J Antimicrob Chemother. 2005 Dec;56(6):1130-3. Epub 2005 Oct 20.

PMID:
16239291
19.

Molecular characterization of the first telithromycin-resistant Streptococcus pneumoniae isolate in Germany.

Reinert RR, van der Linden M, Al-Lahham A.

Antimicrob Agents Chemother. 2005 Aug;49(8):3520-2.

21.

Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003.

Reinert RR, Reinert S, van der Linden M, Cil MY, Al-Lahham A, Appelbaum P.

Antimicrob Agents Chemother. 2005 Jul;49(7):2903-13.

22.

Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe.

Reinert RR, Ringelstein A, van der Linden M, Cil MY, Al-Lahham A, Schmitz FJ.

J Clin Microbiol. 2005 Mar;43(3):1294-300.

23.

Antimicrobial resistance of Streptococcus pneumoniae isolates of outpatients in Germany, 1999-2000.

Reinert RR, Lütticken R, Reinert S, Al-Lahham A, Lemmen S.

Chemotherapy. 2004 Oct;50(4):184-9. Epub 2004 Sep 3.

PMID:
15347911
24.

Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003.

Reinert RR, Franken C, van der Linden M, Lütticken R, Cil M, Al-Lahham A.

Int J Antimicrob Agents. 2004 Jul;24(1):43-7.

PMID:
15225860
25.

High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.

Reinert RR, Lütticken R, Al-Lahham A.

Clin Microbiol Infect. 2004 Jul;10(7):659-62.

26.

Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany.

Reinert RR, Lütticken R, Sutcliffe JA, Tait-Kamradt A, Cil MY, Schorn HM, Bryskier A, Al-Lahham A.

Antimicrob Agents Chemother. 2004 Apr;48(4):1369-73.

27.

Characterization of German penicillin non-susceptible serotype 23F pneumococci using multilocus sequence typing.

Reinert RR, Muckel S, Al-Lahham A, Spratt BG, Brueggemann AB, Hakenbeck R, Lütticken R.

J Med Microbiol. 2003 Nov;52(Pt 11):981-7.

PMID:
14532343
28.

Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany.

Reinert RR, Wild A, Appelbaum P, Lütticken R, Cil MY, Al-Lahham A.

Antimicrob Agents Chemother. 2003 Jul;47(7):2319-22.

29.

Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001.

Reinert RR, Lütticken R, Bryskier A, Al-Lahham A.

Antimicrob Agents Chemother. 2003 Feb;47(2):489-93.

30.

Will the 7-valent pneumococcal vaccine have a similar impact on all invasive pneumococcal infections in children in Germany as in the Kaiser Permanente Trial?

von Kries R, Hermann M, Al-Lahham A, Siedler A, Reinert RR.

Eur J Pediatr. 2002 Dec;161 Suppl 2:S140-3. Epub 2002 Oct 2.

PMID:
12494261
31.

Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children.

von Kries R, Hermann M, Hachmeister A, Siedler A, Schmitt HJ, Al-Lahham A, Reinert RR.

Pediatr Infect Dis J. 2002 Nov;21(11):1017-23.

PMID:
12442022
32.

Characterization of clinical Streptococcus pneumoniae strains from Germany with decreased susceptibility to fluoroquinolones.

Reinert RR, Al-Lahham A, Lütticken R, Boos M, Schmitz FJ.

J Antimicrob Chemother. 2002 Jun;49(6):1015-8.

PMID:
12039895
33.

Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany.

Reinert RR, Al-Lahham A, Lemperle M, Tenholte C, Briefs C, Haupts S, Gerards HH, Lütticken R.

J Antimicrob Chemother. 2002 Jan;49(1):61-8.

PMID:
11751768
35.

Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight other antimicrobials.

Reinert RR, von Eiff C, Kresken M, Brauers J, Hafner D, Al-Lahham A, Schorn H, Lütticken R, Peters G; Multicenter Study on Antibiotic Resistance in Staphylococci and other Gram-positive Cocci (MARS) Study Group.

J Clin Microbiol. 2001 May;39(5):1928-31.

36.
37.

In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany.

Lemmen S, Al-Lahham A, Lütticken R, Reinert RR.

Chemotherapy. 2001 Mar-Apr;47(2):104-9.

PMID:
11173811
38.

In vitro activity of gatifloxacin against Streptococcus pneumoniae isolates in Germany.

Reinert RR, Al-Lahham A, Lemmen S, Lütticken R.

J Antimicrob Chemother. 2000 Nov;46(5):854-6. No abstract available.

PMID:
11062219
39.

Biosynthesis of phytochelatins in the fission yeast. Phytochelatin synthesis: a second role for the glutathione synthetase gene of Schizosaccharomyces pombe.

Al-Lahham A, Rohde V, Heim P, Leuchter R, Veeck J, Wunderlich C, Wolf K, Zimmermann M.

Yeast. 1999 Mar 30;15(5):385-96.

40.

Prevalence of Salmonella, Shigella and intestinal parasites in food handlers in Irbid, Jordan.

al-Lahham AB, Abu-Saud M, Shehabi AA.

J Diarrhoeal Dis Res. 1990 Dec;8(4):160-2.

PMID:
2081882
41.

A hemolytic protein secreted from epidermal cells of the Arabian Gulf catfish, Arius thalassinus (Ruppell).

Al-Lahham A, Al-Hassan JM, Thomson M, Criddle RS.

Comp Biochem Physiol B. 1987;87(2):321-7.

PMID:
3621901

Supplemental Content

Loading ...
Support Center